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ABSTRACT OF DISSERTATION

ANTERIOR CRUCIATE LIGMAENT INJURY-INDUCED ALTERATIONS IN
INFLAMMATION AND MUSCLE PHYSIOLOGY
Long term weakness and atrophy of the quadriceps muscle are a direct result of
anterior cruciate ligament (ACL) injuries and persist for up to 10 years post injury.
Muscle atrophy ensues regardless of ligamentous reconstruction surgery, indicating that
muscle atrophy following injury is a function of the ligament rupture and not
reconstruction surgery. Elucidating the mechanisms underlying quadriceps atrophy
following ACL rupture is crucial for developing interventions to restore proper
quadriceps size and mitigate weakness thereby allowing for improved patient function. In
addition to understanding the specific mechanisms that contribute to quadriceps atrophy
following ACL rupture, the timing of atrophic events that cause the decreased function of
the quadriceps muscle must be elucidated to determine the best intervention strategy.
Most studies involving human subjects are conducted post ACL reconstruction with
limited emphasis on the cellular changes in muscle that could be responsible for the
observed atrophy and weakness. Animal models involving open-knee surgery for ACL
transection have been employed to investigate cellular mechanisms in muscle, but these
models are not mimicking the human ACL rupture, which is a closed-knee injury. Thus,
there is a need for fundamental research of the timing and underlying mechanisms of
inflammation and quadriceps atrophy following ACL injury.
The purpose of this dissertation is twofold: Firstly, to examine the relationship
between serum and synovial joint inflammatory markers and proteomics in ACL
deficient subjects; and to use those acquired data to identify potential cellular processes
that may influence skeletal muscle and track those processes longitudinally in
conjunction with changes in muscle size following a closed ACL injury in a rat model.
The goals of these studies were to determine if a closed ACL rupture in the absence of
surgical repair would induce persistent quadriceps atrophy, determine the relationship
between ACL rupture and intra-articular and systemic inflammation, and investigate
time-dependent cellular changes in the vastus lateralis muscle. Results indicate there is an
increase in inflammatory cytokines (IL-1b (interleukin 1-beta) and IL-6(interleukin six))
in both the synovial joint fluid and systemic circulation following injury in humans. In

the in vivo animal model of ACL rupture quadriceps atrophy was observed one week post
injury, but muscle size unexpectedly recovered as early as 2 weeks. Gene expression of
MAFbx and Murf-1 (atrophy markers) was elevated as early as 48 hours after ligament
rupture. No signs of muscle damage were observed at any time point. This dissertation
provides the first longitudinal investigation into the changes in muscle physiology
following a closed ACL-rupture, informed by a proteomic analysis of human serum and
synovial fluid after an acute clinical ACL tear. The results of these studies begin to
characterize a relationship between joint inflammation and muscle atrophy in the acute
time period following ACL injury.
KEYWORDS: Anterior Cruciate Ligament Injury, Inflammation, Quadriceps, Atrophy
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CHAPTER 1. INTRODUCTION
Background
Anterior cruciate ligament (ACL) tears are one of the most common orthopedic
injuries affecting more than 200,000 people a year, of all ages and activity levels.1 The
complete tearing of this static stabilizer in the knee causes a cascade of events that
ultimately leads to long-term dysfunction of the knee joint and quadriceps muscle. The
quadriceps muscle is a group of four muscles working synergistically to extend the knee
and provide dynamic stabilization and shock absorption.2 Persistent quadriceps weakness
and atrophy is a hallmark of ACL injury and arguably the most detrimental result.
Atrophy and weakness of this muscle group persists long after the injury and even
surgical intervention causing joint instability,1,3 altered gait4, muscle activation failure5,
and may contribute to the development of osteoarthritis.6,7
In the wake of an ACL rupture there is a sustained increase in intraarticular
inflammatory cytokines and cartilage breakdown markers present in the joint.8-14 The
increase in inflammation within the synovial environment is important because chronic
inflammation could be a contributing factor to alterations in the systemic environment as
well as joint degradation15 and potential muscle atrophy.16 The exact mechanism leading
to quadriceps atrophy following injury is still unknown, but a link between the
quadriceps and neural alterations has been well established.17-19 There is also evidence to
support a potential cellular cross-talk between the joint and the muscle20 indicating that
alterations to the quadriceps following ACL injury is multifactorial. Research efforts
focused on the effects of ACL rupture on the quadriceps muscle tend to be confounded
by limitations in human research and studies whose patient populations are post-surgical.
1

ACL rupture causes a deleterious cascade of events that includes joint inflammation,
changes to the systematic environment and alterations to the quadriceps muscle. Changes
to the local, systemic and muscular environment likely all contribute to the atrophy and
muscle weakness seen clinically and elucidating the mechanisms responsible for atrophy
and quadriceps dysfunction will aid in the development of interventions and treatment.
The goal of ACL reconstruction surgery is to reinstate joint stability but even this
stabilizing surgery has the potential to present an additional inflammatory burden to the
joint21 and create an environment of sustained inflammation. This dissertation will begin
to dissect how ACL injury affects the synovial fluid environment, the circulating serum
in human patients and the quadriceps muscle using a novel pre-clinical animal model.

Quadriceps Atrophy Regardless of Reconstruction
The current standard of care in the US is to reconstruct an ACL after injury surgically
in order to restore biomechanical stability. Human research centered around the changes
in muscle morphology following ACL injury is mostly cross-sectional in design and
confounded by the presence of joint surgery. Non-operative treatment of ACL injury is
less common, but the question becomes whether patients that remain ACL deficient also
undergo weakness and atrophy like those who have surgery. Conservative treatment
following ACL injury is centered around regaining quadriceps strength along with
normal mobility. The quadriceps and hamstring muscle groups have to be working
synergistically in order for the knee joint to regain normal biomechanical function post
ACL injury and the strength in both groups should be comparable to that on the noninjured leg.
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As far back as the 1960s Edstrom22 showed muscle atrophy in myosin type I fiber
atrophy following chronic ACL injury. His group followed eight cases of patients with
torn ACLs and demonstrated that five out of the eight patients with a chronic ACL injury
had significant statistical differences in fiber type cross sectional area between the “red”
and “white” fibers. Edstrom made a case of selective atrophy of the quadriceps muscle
due to disuse.22 Tegner et al. in 198423 measured the isokinetic quadriceps and hamstring
strength of sixteen patients with “old” anterior cruciate ligament tears after undergoing a
twelve-week long thigh musculature strengthening program. Researchers found that
before the training period quadriceps strength was significantly decreased compared to
the non-injured limb. Over the next two time points, quadriceps strength increased but
never reached the level of the non-involved limb and remained significantly different.23
These studies indicate that patients who suffer from ACL rupture will have decreased
strength long term even after rehabilitation.
Chapter two of this dissertation will discuss whether conservative treatment of ACL
injury yields outcomes similar to reconstruction surgery. Patient reported function is not
different between patients treated non-operatively and patients treated with reconstruction
suggesting that surgery is not necessary to be functional in all cases.24 There is also
evidence to suggest that the severity of the injury may have a role in the development of
quadriceps weakness but overall those with a complete tear of the ACL had poor to fair
muscular strength eight years after injury.25 In a comprehensive study done by Tsepis in
200626, patients with an ACL injury were broken up into three groups depending on the
length of time since injury. The short time group (less than six months) and then a
medium (6 to 18 months) and a long-term group (average of 56 months). Quadriceps
3

strength was decreased by at least 20% percent for all groups compared to healthy control
subjects.26 This shows a persistence of muscle weakness and decrease in cross sectional
area5 well after injury and without reconstruction. While some studies showed less
weakness such as Patel et al., 200327 and Kvist et. al, 200128, all of the studies reported at
least a 7% deficit in involved quadriceps strength. Chapter two of this dissertation is a
critically appraised topic that will discuss the effect of non-operative ACL treatment on
isokinetic muscle strength, function and patient reported function. Atrophy and weakness
of the quadriceps muscle persists regardless of reconstruction, and patients who remain
ACL deficient (ACLD) will continue to have quadriceps atrophy and joint dysfunction
years following ACL injury. Research focused on the specific alterations in quadriceps
function before reconstruction is lacking and there is a need for longitudinal studies to
begin to fill the gaps in knowledge.

Cellular Changes in Quadriceps muscle Following ACL Injury
To start to identify the potential mechanisms of quadriceps atrophy after ACL
rupture, researchers have turned to cellular measures of muscle morphology. Recent
literature reveals differences in physiological cross sectional area (CSA) between injured
and non-injured limbs with the largest decrease in muscle size in the vastus lateralis.29
Furthermore, there was a specific decrease in the CSA of type-IIA muscle fibers
preceding surgery. After reconstruction surgery, the frequency of type IIA muscle fibers
significantly decreased in conjunction with increases in type IIA/IIX hybrid fiber types.30
Muscle biopsies from the vastus lateralis of patients with an ACL injury reveal
differences in physiological cross sectional area and pennation angle30, both of which are
important for proper function of the quadriceps group. Following ACL injury there are
4

also significant increases in fibroblast and collagen content which correlated with
increases in extracellular matrix.30,31 This is important because increases in extracellular
matrix could potentially limit hypertrophy32 and therefore adversely affect function and
recovery from injury. Moreover, the injured limb showed decreases in satellite cell
number30,31, which could lead to a decreased capacity for muscle growth. Additionally,
muscle biopsies from the injured limb had significantly higher myostatin gene expression
and protein abundance.33 Myostatin is a potent negative regulator of muscle size34 and
increases in myostatin may be an important factor in quadriceps atrophy following ACL
injury. In addition, myostatin and TGF-b levels in serum were also increased following
ACL reconstruction.35 Along with TGF-b, muscle from the injured limb also has
increased protein abundance of the inflammatory cytokines IL-6 and TNFa. 33 Elevations
in proinflammatory cytokines in serum mirror what is occurring in the joint post injury,
for example elevations in both synovial fluid pro-inflammatory cytokines like IL-6 are
similar to increases in cytokine receptor pathways in human serum. Increases in
inflammatory cytokines may lead to a state of sustained inflammation providing a
connection between the two environments. Changes in cross sectional area, extracellular
matrix, muscle growth regulators and satellite cells provide compelling evidence that
ACL injury causes a myriad of detrimental changes to the quadriceps muscle. There are
also increases in apoptosis and denervated muscle fibers31 which could potentially
explain some of the neurogenic response seen in patients after this injury. There is an
abundance of literature to support alterations in neural feedback in the quadriceps after
injury.17-19 Increases in denervated muscle fibers could begin to explain the quadriceps
inhibition and lack of motor recruitment that is associated with weakness after ACL
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rupture. This evidence demonstrates changes within the muscle itself following injury
that likely work in combination to create changes within the neural feedback network that
contributes to weakness.
The literature presented above provides insight into understanding the complicated
response of the quadriceps muscle to ACL rupture. It should be noted that the average
time of the muscle biopsies in the above studies was 60 days post injury and therefore
early events underlying muscle changes remain largely unknown. There is also a
limitation in the number of muscle biopsies that can be collected from human subjects
with the majority of studies presented here just looking at biopsies from pre- to postreconstruction. Surgery presents a new insult to the joint and it is still unclear if that
insult will further modify the quadriceps. Only having one time point pre-surgery
prohibits a complete picture of longitudinal changes occurring after injury from being put
together. To augment the knowledge base while there is a lack of longitudinal human
studies, animal models of ACL injury allow for a more in depth analysis of the
quadriceps.

Animal Models of ACL Injury
The use of animal models allows researchers to study multiple time points post injury.
Additionally, with animal models comparison between injured and non-injured limbs can
be easily obtained. Also, animal studies provide more feasibility in the timing of sample
collection allowing for longitudinal studies targeted at determining quadriceps changes
during the acute post-injury period. Studies utilizing ACL transection models examined
changes in quadriceps physiology at one, two, three, seven and fifteen days post
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transection.36,37 Both studies show significant increases in two markers of muscle
catabolism Murf-1 and Mafbx from days 1-3 over the control and sham groups.36,37
Increases in these markers are important because Murf-1 and Mafbx are two ubiquitin
ligases that are associated with protein breakdown and atrophy within skeletal muscle and
have been shown to be upregulated in most atrophy models. 38,39 Additionally, muscle
mass loss is preceded by the upregulation of Murf-1 and Mafbx.38,39 Similar to the human
studies outlined above33,35, significant increases in myostatin over the early post
transection period that persisted out to seven days post-surgery coincide with decreases in
muscle wet weight and cross sectional area.36,37,40 Furthermore, decreases in muscle fiber
CSA and significant increases in Murf-1 and Mafbx mRNA are found 60 days post ACL
transection, indicating that increases in muscle atrophic signaling are present after the
acute recovery period.41
While increases in synovial inflammation indicate that an animal model of ACL
transection will undergo a similar inflammatory response to that of humans within the
knee joint.41 One important consideration when looking at animal models of ACL
transection as an injury is that surgically transecting the ACL may not be as clinically
relevant since surgical transection creates inflammatory and atrophic processes that
mimic ACL reconstruction surgery.36,42 The additional surgery in order to achieve
transection of the ACL in traditional animal models has the potential to create an inflated
inflammatory response which makes it more difficult to discern which alterations in
quadriceps muscle are due to the ruptured ligament as opposed to a state of increased
inflammation after a surgery. This distinction may be important as there is evidence to
support that any intraarticular inflammation may play a role in muscle atrophy by
7

inducing Murf-1 by upregulations in NF-kb and TNF signaling pathways.16,43
Furthermore, it has been shown that pro-inflammatory cytokines like IL-6 have the
ability to induce muscle atrophy by decreasing phosphorylation of ribosomal S6 kinase.44
It is highly likely that inflammation plays a large role in the induction of atrophy post
ACL rupture and therefore ACL transection models requiring open surgery may not be
best to study this injury since an increase in inflammation will confound the effects to the
quadriceps muscle.

Goal of Dissertation
There is a fundamental lack of knowledge about the mechanisms underlying
quadriceps atrophy following ACL injury. There is evidence for cellular changes to the
quadriceps muscle, but in humans the data are primarily cross sectional and lacks
consistent study time points. Moreover, human studies have mainly focused on
quadriceps atrophy following reconstruction and not just injury. However, atrophy is
present regardless of ACL reconstruction indicating that the initial ligament rupture is a
contributing factor. There is a need for a clinically relevant non-transection model of
ACL injury to longitudinally track alterations in the quadriceps muscle.
In this dissertation we proposed to examine the connection between synovial joint
inflammation and quadriceps atrophy following ACL injury in both human and animal
models. Quadriceps deficits following injury are present with or without reconstruction,
indicating that quadriceps atrophy is present even in ACL deficient patients. Next, in
chapter three, we examine the inflammatory response in human synovial fluid following
ACL injury and see that injury causes a sustained increase in proinflammatory cytokines
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IL-1b and IL-6. Based on the inflammatory response in the synovial joint, human serum
was profiled to determine if increases in circulating markers of inflammation was similar
to synovial fluid and if these proteins have the potential to influence the catabolic balance
of skeletal muscle. As such, chapter four chapter focuses on human serum proteomics
following ACL injury. The results of that study indicate systemic increases in not only
inflammation but also muscle specific markers like myoglobin, which traditionally used
as a “stress” marker for muscle and while this specific marker was not pursued farther, it
raised questions about potential muscle damage following ACL injury. Our hypothesis is
that the vastus lateralis is subjected to damage during ACL tear leading to atrophy and
dysfunction. To test this hypothesis, a novel in vivo animal model of ACL tear was used.
The model consists of a device that will mechanically overload the tibia in relation to the
femur, tearing the ACL. By tearing the ACL in a closed system where there is no increase
in inflammation from a surgery, makes this clinically relevant model of injury. Our team
now has the ability to study the quadriceps muscle acutely after injury allowing us to
answer questions about the quadricep muscles response to ACL rupture alone at various
time points after injury. Chapter five describe results from the animal model focusing on
damage and atrophy markers acutely after ACL rupture.

9

CHAPTER 2. THE EFFECTIVENESS OF NON-OPERATIVE TREATMENT FOR ANTERIOR
CRUCIATE LIGAMENT RUPTURE ON PATIENT REPORTED OUTCOMES AND MUSCULAR
STRENGTH: A CRITICALLY APPRAISED TOPIC

Abstract
Clinical Scenario: Anterior Cruciate Ligament (ACL) ruptures are one of the most
common injuries in young athletic populations. The leading treatment for these injuries is
anterior cruciate ligament reconstruction (ACL-r), however, non-operative treatments are
also utilized. Following ACL-r, patients experience prolonged muscle weakness and
atrophy of the quadriceps muscle group, regardless of rehabilitation. Non-operative
treatment plans following ACL injury exist, but their outcomes are less familiar, in spite
of providing insight as a non-surgical ‘control’ for post-surgical rehabilitation outcomes.
Therefore, the purpose of this critically appraised topic (CAT) was to evaluate quadriceps
strength and function following non-operative ACL rehabilitation using objective and
subjective measures including: Isokinetic dynamometry; the Single Leg Hop Test; and
the International Knee Documentation Committee Subjective Knee Form (IKDC).
Focused Clinical Question: In patients who have sustained an anterior cruciate ligament
rupture, what are the effects of non-operative treatment on peak isokinetic knee extensor
torque, the Single Leg Hop Tests and the IKDC? Key Findings: Patients who underwent
non-surgical ACL treatment produced limb symmetry index (LSI), the side-to-side torque
difference expressed as a percentage, values at or above 90% for all four Single Leg Hop
Tests and strength tests similarly to ACL-r patients. All studies showed individuals had
higher IKDC scores at baseline collection when compared to patients who underwent
ACL-r but showed lower IKDC scores at long term follow up compared to ACL-r
patients. Clinical Bottom Line: Non-operative treatments of ACL injuries yield similar

long-term results in quadriceps strength as ACL-r. Due to the quality of evidence and the
absence of randomized controlled trials on this topic, these outcomes should be
considered with caution. Strength of Recommendation: The Oxford Centre for EvidenceBased Medicine taxonomy recommends a grade of B for level 2 evidence with consistent
findings.
Keywords: ACL, treatment, muscle strength, function
Full Reference: Hunt, E. R., Parise, C. N., & Butterfield, T. A. (2020). The Effectiveness
of Nonoperative Treatment for Anterior Cruciate Ligament Rupture on Patient-Reported
Outcomes and Muscular Strength: A Critically Appraised Topic. Journal of Sport
Rehabilitation, 1(aop), 1-6.
Clinical Scenario
Anterior cruciate ligament (ACL) injuries, are among the most common traumatic
athletic injuries, affecting upwards of 200,000 individuals per year in the United States
(US).1 For those US patients who wish to continue participation in competitive athletics,
ligament reconstruction has become the preferred method of treatment.45 In the US, the
rate of ACL reconstruction continues to rise annually, reaching 52 reconstructions per
100,000 of the population in 2015.46 This rate is second to Australia, who continues to
lead the world with 77.4 ACL reconstructions per 100,000 citizens, with the greatest
increase in ACL reconstructions among those 4-15 years of age.47
The primary purpose for ACL reconstruction (ACL-r) is the restoration of joint
congruity concomitant with increased knee stability.48 However, despite the
advancements and improvements in surgical techniques, instrumentation, and postsurgical care and rehabilitation, individuals who undergo ACL–r inevitably suffer from
persistent quadriceps atrophy and weakness long term.49 These unresolved strength
11

deficits decrease athletic performance, increase the risk of re-injury,50 and likely
contribute to the progression of cartilage damage within the joint.51 Therefore, the dogma
that ACL-r is the most efficacious treatment following ACL injury should be taken with
caution. In a twenty-one-year population study, Sanders et al., found that out of almost
two thousand patients, 75% of them underwent ACL-r and 98% of those were under the
age of 18.24 Although the rates of non-operative treatment of ACL injury continue to lag
behind the rate of surgical intervention in the US, there is growing support within the
international community for conservative treatment. Therefore, the purpose of this
critically appraised topic is to review the best, and most current literature that measured
the effects of conservative, non-operative ACL treatment on quadriceps strength and
patient perceived function using Isokinetic dynamometry; the Single Leg Hop Test; or the
International Knee Documentation Committee Subjective Knee Form (IKDC).

Focused Clinical Question
In patients who have sustained an anterior cruciate ligament rupture, what are the
effects of non-operative treatment on isokinetic muscle strength, the Single Leg Hop
Tests and the IKDC-2000?

Search Strategy
In November of 2018, we performed a comprehensive computerized search using the
following terms (Figure 2.1), using the PICO strategy. 52
•

Patient/Client group: anterior cruciate ligament rupture

•

Intervention: non-operative treatment protocol
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•

Comparison: ligamentous reconstruction OR no

•

Outcome: patient reported outcomes AND muscular strength

2.1.1

Sources of Evidence Search
•

EBSCOhost
o CINAHL
o SPORTDiscus
o Medline
o Additional resources obtained via review of
reference list and hand search

Inclusion and Exclusion Criteria
The criteria for inclusion were as follows:
•

Studies that investigated the effectiveness of non-operative treatments

•

Studies that investigated ACL ruptures

•

Studies that included outcome measures of patient reported outcomes or muscular
strength

•

Limited to studies published within the past 10 years (2008-2018)

•

Limited to English

•

Level 2 evidence or higher

The criteria for exclusion were as follows:
•

Studies that investigated non-ACL ruptures (i.e. ACL partial thickness tear)

•

Studies that investigated other subsequent pathologies because of ACL injury
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•

Studies that did not investigate the effects of non-operative treatment on ACL
injury

•

Studies that were not in English

•

Level 3 evidence or lower

•

Systematic reviews and meta-analysis

2.1.2

Evidence of Quality Assessment
The Strengthening of Reporting of Observational studies in
Epidemiology (STROBE) Statement was used to determine the
validity of the included studies. Two authors (EH, CP)
independently scored and reviewed each of the articles, after
review both authors (EH, CP) reached an agreement about study
quality and inclusion.

Summary of Search and Key Findings
•

The literature search returned 43 studies (Figure 2.1) related to the clinical question.
After review 39 studies were excluded because they did not meet the inclusion
criteria for this CAT. Four prospective cohort studies48,53-55 met inclusion criteria and
are described in Table 1.

•

Each included study evaluated the effects of non-operative treatment algorithms for
ACL injury or compared conservative treatment and ACL-r.

•

Collectively, the four studies (Table 2.1) reported significant improvements in both
patient reported outcomes and muscular strength when comparing long term follow
up to the time of injury. In addition, in the studies that compared the effects of non14

operative treatment with ACL-r, outcome measures were similar between the two
groups.

Results of Evidence Quality Assessment
Four studies were identified as the best evidence and selected for inclusion in this
critically appraised topic (CAT). The four studies were selected because they were level 2
evidence and had STROBE scores of at least 17/22. Three studies 48,54,55 examined the
effects of non-operative treatment on isokinetic strength of the quadriceps and
hamstrings. In addition, studies conducted by Moksnes et al., 48,53,54 examined the effects
of non-operative treatment on strength using the Single Leg Hop Test and Moksnes et al.
2009, was the only study to compare the non-operative ACL group directly to the ACL-r
group. All four studies examined the effects of non-operative ACL treatment on the
IKDC 2000. 48,53-55 Moksnes et al., 2008 received a validity score of 18/22 for failure to
include the study design in the abstract, address potential sources of bias and discuss the
external validity of the study. Moksnes et al., 2013 did not discuss potential confounders
of each variable or the external validity of the study.

Clinical Bottom Line
There is strong evidence to support that conservative treatment of ACL injuries
obtains similar outcomes as ACL ligamentous reconstruction at long-term follow up
periods. All studies included in this critically appraised topic,48,53-55 generated similar
results: at follow up patients who underwent non-surgical treatment of ACL injury
produced LSI values at or above 90% for all four Single Leg Hop Test, as well as, knee
extensor and flexor isokinetic muscular strength. In addition, all studies showed
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individuals had higher IKDC-2000 scores (higher scores indicate better knee function) at
baseline collection when compared to patients who underwent ACL-r but showed lower
IKDC-2000 scores at long term follow up compared to ACL-r patients. There is grade B
evidence that non-operative treatment yields satisfactory results in the long term. The
Oxford Centre for Evidence-Based Medicine taxonomy recommends a grade of B for
level 2 evidence with consistent findings.56

Implications for Practice, Education and Future Research
The prevalence of ACL injuries in athletes is increasingly escalating. While ACLr is the current favored treatment, it is important that all treatment options are carefully
examined in order to provide patients with the most efficient and effective care.
Therefore, this critically appraised topic was completed to evaluate the best literature
regarding the use of non-operative treatment regimens for ACL injuries. Four cohort
studies were included in the investigation. From these four studies, the main findings
were concluded that non-surgical treatment of ACL injuries could yield satisfactory
results when outcome measures include the IKDC-2000 at baseline, Single Leg Hop Test,
and isokinetic muscle strength.
The IKDC is a knee specific, patient reported assessment tool used to evaluate
symptoms, function during daily activities and levels of symptom free sports-activity.57 It
has been determined to be a reliable and valid instrument for the outcome measures
mentioned above and was therefore seen as an appropriate tool to be used in this critically
appraised topic.58,59 However, it should be noted that in a study conducted by Kessler et
al.,60 the IKDC scores were determined based upon tibio-femoral anterior-posterior
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translation. Because patients who undergo ligamentous reconstruction have inevitable
restoration of ligamentous stability, the comparison of anterior-posterior translation
between groups of non-operative and ACL-r groups is not informative. Due to the use of
this criteria as a scoring variable, future studies should take caution when using the IKDC
as a tool of comparison between conservatively treated and ACL-r groups. It is important
to note that while patient reported outcomes are reliable and valid tools, they are
subjective to normal patient function and how the patient feels during a given time-frame.
Several studies48,55 showed that patients who opted to go through non-operative treatment
presented with better IKDC-2000 scores at baseline. However, the patient population of
these non-operative groups was significantly older than the patients who decided to go
through with ACL-r and had an altogether lower activity level. This suggests that
activities of daily living and pre-injury activity level are important factors when it comes
to deciding between ACL-r and conservative treatment options.
Unfortunately, persistent quadriceps weakness has become a comorbidity to ACLr and has spurred many novel treatments, rehabilitation programs and medical
technologies in attempts to address this issue. However, strength deficits of 20% lasting
for over two years have still been documented following ACL-r61-63. In three of the four
studies included in this critically appraised topic, isovelocity torque output was used as a
measure of quadriceps and hamstring strength in subjects treated conservatively
following ACL injury53-55 All three studies used the following standard procedure: 10minute warm-up on a stationary bike followed by four practice trials performed with
submaximal effort at 60°/sec. Finally, five test repetitions were performed with maximal
effort at the same angular velocity of 60°/sec, starting with the uninvolved limb. Strength
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deficits between extremities were reported as a limb symmetry index (LSI), or simply the
side-to-side torque difference expressed as a percentage (peak torque of involved limb)/
(peak torque of uninvolved limb) x 100. Although LSI values <90% are considered
abnormal,64 Moksnes et al. 2007, and Moksnes et al. 2013 all reported quadriceps and
hamstring LSI values at or above 90% at baseline and follow up. Moreover, Grindem et
al. 2014 further reported that only nine out of 43 non-surgically treated patients exhibited
quadriceps and hamstring LSI values of <90% at follow up. These findings demonstrate
that non-operative treatments of ACL injuries have the possibility to produce desirable
muscle strength.
The Single Leg Hop Tests have been shown to be reliable and valid tests used to
measure neuromuscular control and strength in the limb.65-67 The test only requires a
standard tape measure making it accessible to clinicians in a variety of settings, and
deficits between extremities can easily be reported as LSI values. Moksnes et al. 2013
reported LSI values at or above 90% for all Single Leg Hop Tests at baseline and at all
follow up periods (1 year and 2 years). Additionally, Moksnes et al. 2009 and Grindem et
al. 2014 reported LSI values above 90% for all Single Leg Hop Tests at follow up,
demonstrating that non-surgical treatments of ACL ruptures can improve neuromuscular
control, strength and confidence as measured by the Single Leg Hop Test.
Interestingly, all of the studies included in this CAT report baseline LSI values at
or above 90%. This could be due to baseline outcomes being measured at least 6 months
after injury. Outcome measures examined by Moksnes et al. 2008 did not get evaluated
until at least two years after ACL injury. Additionally, it was routine for patients that
were included in these studies to undergo pre-operative rehabilitation sessions to resolve
18

initial impairments of ACL injury. Recently, it was shown that patients who underwent
ACL-r were typically returned to contact sports within six-months post-surgery.64,68
Gridnem et al., reported that athletes who were treated non-operatively returned primarily
to non-pivoting sports. Whether functional and strength differences exist between
conservative and surgical treatment at the time when most highly active individuals are
returned to sport is unknown and should be the focus of future studies.
The findings of this CAT imply that non-operative treatments of ACL injuries are
adequate options in restoration of patient function, as well as patient strength at long term
follow ups. However, patient goals, normal activities of daily living and sport activity
level should all be taken into consideration when choosing the best treatment plan for
patients. Furthermore, the absence of randomized control trials on this topic hinder the
strength of these recommendations. While further investigation regarding this topic is
warranted, patients should be thoroughly informed of all treatment options available.
Evidence suggests that conservative treatment has the ability to generate positive
outcomes in the long term and should be considered for ACL-deficient individuals.
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Table 2.1 Characteristics of Included Studies
Study 1
Study 2

Study 3

Study 4

Moksnes et al.
2008

Moksnes et al.
2009

Moksnes et al.
2013

Grindem et al.
2014

Study/Design

Prospective
cohort study

Prospective
cohort study

Prospective
cohort study

Prospective
cohort study

Participants

26 patients, 11
girls and 15
boys were
included
throughout the
entirety of the
study. 20
patients were
treated nonoperatively
while 6 patients
were treated
with ACL-r.

At baseline, 125
patients, 56
females and 69
males (age 27.2
± 8.6). At
follow up 102
patients
remained. 52
patients in the
non-operative
group and 50
patients in the
ACLreconstruction
(ACL-r) group.

46 patients, 16
females and 30
males (age at
baseline 11.8 ±
1.3). 34
patients
remained in the
non-operative
treatment
group and 10
patients opted
to undergo
ACL-r.

143 patients,
80 females and
63 males were
included in the
study. 43
patients chose
to be treated
nonoperatively
and 100
patients were
treated with
ACL-r.

Inclusion

ACL injury
before the age
of 13, two years
from injury to
or
reconstruction
to follow up
period, ACL
rupture
confirmed by
magnetic
resonance
imagining,

Level 1 or level
2 activities,
unilateral ACL
rupture.

Traumatic
complete
intrasubstance
ACL injury
sustained at the
age of 12 or
younger

ACL injury
within past 3
months, MRI
diagnosis,
3mm
difference
between knees
using KT1000, 13-60
years old,
participate in
level 1 or level
2 activities at
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clinical
examination by
one experienced
orthopedic
surgeon and
positive
Lachman’s test.

least 2x a
week.

Exclusion

ACL avulsion
injury, posterior
cruciate
ligament injury
or intraarticular
fractures.

Posterior
cruciate
ligament injury,
intraarticular
fractures,
symptomatic
meniscal injury,
cartilage injury
affecting the
subchondral
bone plate, or
any other injury
to the leg.

Tibial or
femoral ACL
avulsion
fractures

Current or
pervious
injury to
contralateral
leg if MRI
showed
another grade
3 ligament
injury, fracture
or fullthickness
articular
cartilage
damage or
patients with
symptomatic
meniscal
injury

Follow up
Periods

Follow Up:
taken at a
minimum of 2years post ACL
injury.

Baseline:
Taken after 3
months of
rehabilitation
program.
Baseline testing
within first 6months post
index injury
1 Year Follow
Up: One year
after baseline
measurement

Baseline:
Taken after
patient
completed
phase two of
the
rehabilitation
program
previously
published by
the
investigators
and could
perform single

Baseline:
Taken at a
mean of 2months post
injury. Before
baseline,
completed
rehabilitation
to resolve any
initial
impairments
from the
injury.
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OR one year
after ACL-r.

legged hops
without pain.
Mean time
from injury to
baseline testing
was 11.7 ± 11.5
months.
1 Year Follow
Up: One year
post baseline
2 Year
Following up:
Two-years post
baseline

Six-week test:
taken after
participation
in the 5-week
rehabilitation
protocol
described by
Eitzen et al.
2- year follow
up: taken 2
years after 6week test or 2
years after
ACL-r.

Outcome
Measure(s)

Single legged
hop tests (single
hop, triple hop,
triple crossover
hop, 6-m timed
hop), IKDC
2000, isokinetic
muscle strength
of knee

Single legged
hop tests (single
hop, triple hop,
triple crossover
hop, 6-m timed
hop), IKDC
2000

IKDC 2000
(with the help
of a parent),
isokinetic
muscle strength
of the knee, the
four Single
legged hop
tests.

Isokinetic
muscle
strength of the
knee, IKDC2000

Main
Findings

IKDC mean
score of 85 (7195). All Single
legged hop tests
above 90% LSI.
Both quadriceps
and hamstring
strength were
above 90% LSI.

At Baseline:
subjects who
were older,
performed
better on the
triple crossover
and 6-m time
hop, and had
better IKDC
2000 scores
opted to go
through with
non-operative
treatment.
1 Year Follow
up: Non-

77% of
children
remained ACL
deficient
throughout 2
years. 91% of
ACL deficient
children
continued to
participate in
pivoting sports.
IKDC 2000
had a mean
score of 82.7 at
baseline and
increased to an

Isokinetic
muscle
strength of
both the
hamstring and
quadriceps
muscle groups
were at or
above an LSI
value of 90%.
There was no
significant
group by time
change
throughout the
course of the
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operative group
preformed
significantly
better on the
single and triple
hop tests. ACLr group had
significantly
higher IKDC
2000

82.9 at 2 year
follow up. Did
not show a
significant
increase in
value over the
course of the
study. All
single legged
hop test above
90% LSI at
baseline. There
was a
significant
change in
Single and 6 m
timed. At
baseline both
quadriceps and
hamstring LSI
strength
measurements
were above
90%. No
significant
change in
either over 2
years

study. IKDC
scores
increased
throughout the
2-year study,
again
however, there
was not a
significant
group by time
relationship.

2b According
to the Oxford
Centre for
EvidenceBased
Medicine
taxonomy.

Level of
Evidence

2b According to
the Oxford
Centre for
Evidence-Based
Medicine
taxonomy.

2b According to
the Oxford
Centre for
Evidence-Based
Medicine
taxonomy.

2b According
to the Oxford
Centre for
EvidenceBased
Medicine
taxonomy.

Validity
Score

18/22

17/22

17/22
21/22
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Conclusion

At two years
after ACL
injury, ACL
deficient
patients had
adequate knee
function.

A majority of
the individuals
who were
treated with a
conservative
treatment
algorithm were
able to return to
pre-injury
activity level. In
addition, when
compared to
individuals who
underwent
ACL-r, nonoperative
subjects had
similar
performancebased outcome
measures.
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Majority of
children
remained ACL
deficient and
had adequate
knee function.

At 2-years
post-injury,
the nonsurgically
treated group
had LSI values
>90 for both
knee extension
and flexion.
The IKDC2000 scores
improved over
2 years.

Figure 2.1 Summary of Search History and Included Studies

CHAPTER 3. ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION REINITIATES AN
INFLAMMATORY AND CHONDRODEGENERATIVE PROCESS IN THE KNEE JOINT

Abstract
Anterior cruciate ligament (ACL) injury leads to a sustained increase in synovial fluid
concentrations of inflammatory cytokines and biomarkers of cartilage breakdown. While
this has been documented post-injury, it remains unclear whether ACL reconstruction
surgery contributes to the inflammatory process and/or cartilage breakdown. This study is
a secondary analysis of 14 patients (9 males/5 females, mean age=19, mean BMI=28)
enrolled in an IRB-approved randomized clinical trial. Arthrocentesis was performed at
initial presentation (mean=6 days post-injury), immediately prior to surgery (mean=23
days post-injury), one-week post-surgery, and one-month post-surgery. ELISA kits were
used to determine concentrations of C-telopeptide fragments of type II collagen (CTXII),
IL-6 and IL-1b in the synovial fluid. The log transformed IL-1b was not normally
distributed; therefore, changes between time points were evaluated using a nonparametric Kruskal-Wallis one-way ANOVA. IL-1b concentrations significantly
increased from the day of surgery to the first postoperative time point (p<.001) and
significantly decreased at the 4-week postoperative visit (p=.03). IL-1b concentrations at
the 4-week postoperative visit remained significantly greater than both preoperative time
points (p >.05). IL-6 concentrations at 1 week post-surgery were significantly higher than
at initial presentation (p=0.013), the day of surgery (p<0.001), and 4 weeks after surgery
(p=0.002). CTX-II concentrations did not differ between the first three time points
(p>.99) but significantly increased at 4 weeks post-surgery (p<.01). ACL reconstruction
appears to reinitiate an inflammatory response followed by an increase in markers for
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cartilage degradation. ACL reconstruction appears to initiate a second “inflammatory hit”
resulting in increased chondral breakdown suggesting that post-operative
chondroprotection may be needed.

Introduction
Anterior cruciate ligament (ACL) injury is one of the most prevalent
musculoskeletal injuries affecting young athletic populations with an incidence of
200,000 persons per year.69 Post traumatic osteoarthritis (PTOA) is an unfortunate
consequence of ACL injury, with 50%-60% of patients exhibiting detectable radiographic
changes consistent with osteoarthritis (OA) as early as 5 years and clinical symptoms of
OA within ten years following the injury.70,71 Previous72,73 studies have indicated that
ACL rupture begins a deleterious cascade of events that include an increase in
inflammatory cytokines and collagen breakdown markers within the joint following
injury.9,11-14,74-76
In the United States of America, the overwhelming majority of patients with ACL
injuries undergo ACL reconstruction. The primary goal of ACL reconstruction is to
reestablish joint stability to allow patients to return to their previous level of function.77
Furthermore, reestablishing tibio-femoral kinematics with surgery has the potential to
diminish subsequent cartilage damage;78 however, patients often exhibit signs and
symptoms of PTOA within 10 years of injury regardless of whether or not they undergo
reconstruction.79 Recent data from a large randomized clinical trial investigating surgical
versus non-surgical or delayed surgical treatment of ACL injured patients has raised the
concern that ACL reconstruction leads to an increase in inflammatory makers compared
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to patients that did not undergo surgery. This second “inflammatory hit” has not been
confirmed to date.21
The purpose of this study was to assess inflammatory and cartilage biomarkers
before and after ACL reconstruction to determine if surgery results in a secondary
inflammatory response. We hypothesized that markers of inflammation (interleukin-1b,
(IL-1b), interleukin-6 (IL-6)) would be significantly increased following ACL
reconstruction surgery.

Methods
3.1.1

Patients

Patients with primary ACL injury consented to enrollment in an IRB-approved
randomized clinical trial assessing the use of hyaluronate injection versus placebo one
week post reconstruction (clinicaltrials.gov: NCT03429140). There were no
postoperative differences between the placebo and hyaluronate groups in terms of
cartilage or inflammatory biomarkers, allowing groups to be collapsed for the current
analysis. Patients were enrolled within the first 10 days following ACL injury. To be
included in this study, patients had to have an isolated ACL tear with no concurrent PCL
injury and could not have a grade 3 or higher MCL or LCL injury. Patients were between
the ages of 14 and 32 and were skeletally mature with closed knee growth plates verified
via radiograph. They had to have no history of previous surgery on the ipsilateral or
contralateral knee and their ACL injury had to occur during sports activity. Exclusion
criteria included the ACL injury occurring more than 10 days prior to enrollment,
previous ipsilateral or contralateral knee surgery, intra-articular cortisone injection into
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either knee within 3 months of injury, and a history of any inflammatory disease (Figure
3.1).
3.1.2

Study Design

The current study is a secondary analysis of the previously mentioned randomized trial.
Arthrocentesis was performed on the day of initial presentation (mean = 6 days post
injury), and all patients received a triamcinolone acetonide (Kenalog 40mg) injection at
the time of initial presentation to dampen the inflammatory response.12 On the day of
ACL reconstruction all patients received a knee aspiration (mean = 23 days post injury),
before the surgical procedures began. One week post-operatively patients received a knee
aspiration, were randomized and received an injection of either hyaluronate (Gel-OneÒ,
Zimmer Biomet, Warsaw, IN) or saline. Four weeks post reconstruction all patients
received a final knee aspiration. Synovial fluid was aspirated and immediately
centrifuged at 3,500 rpm for 10 minutes. The supernatant was collected, aliquoted and
stored at -80°C for further analysis.
3.1.3

Biomarker Assays

Synovial fluid biomarkers were assessed using commercially available enzyme linked
immunosorbent assays (ELISA). Assays were run in duplicate, any samples outside of the
limits of detection or quantification were rerun and intra-assay coefficients of variance
were less than 9.5 for all plates. Biomarkers analyzed to assess inflammation included
interleukin one beta (IL-1b) and IL-6 (Meso Scale Discovery). The biomarkers utilized in
the current study follow the recommendations made by the OARSI, Arthritis Research
UK Osteoarthritis, and Crystal Disease Clinical Study Group Expert Working Group.80-82
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3.1.4

Statistical Analysis

Statistical analysis was completed using Sigmaplot v14 software. Data that were not
normally distributed were log transformed.83 For data points that were below the lowest
limit of detection, the manufacturer-provided LLOD value was halved and used for
computation.84 A one-way repeated measures ANOVA was performed to determine
differences between time points. The log transformed IL-1b was not normally distributed;
therefore, changes between time points were determined using a non-parametric KruskalWallis one-way ANOVA. A Holm-Sidak test was utilized for paired comparisons.
Statistical significance was set as P <.05.

Results
Fourteen patients (9 males and 5 females, mean age= 19 ± 2.6, mean BMI= 28 ±
5.0) were included in these analyses. Twelve of the 14 (86%) patients presented with
meniscus pathology that was addressed in surgery (Table 3.1).
IL-1b concentrations one week post-surgery (from 0.04 ± 0.05 to 0.99 ± 1.22
pg/mL) were significantly greater than initial presentation 6 days post-injury (p=0.015)
and were also significantly greater than the day of surgery (p<0.001). By 4 weeks postreconstruction IL-1b concentrations decreased but did not return back to day of surgery
levels (p=0.001). There was a significant decrease in IL-6 from the time of initial
presentation to surgery (p<0.001). IL-6 concentrations at 1 week post-surgery were
significantly greater than initial presentation (2.06 ± 5.10 to 1427.68 ± 920.62 pg/mL,
p=0.013), the day of surgery (p<0.001), and 4 weeks after surgery (p=0.002). Four weeks
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post operatively, IL-6 concentrations remained significantly higher than the day of
surgery (p<0.001, Figure 3.2).

Discussion
The results of this study support the theory that ACL reconstruction represents a “second
hit” to the injured knee joint. There is a well-documented elevation in inflammatory and
cartilage breakdown markers in synovial fluid following ACL injury.9,11,13,74,85 Despite
preoperative administration of intraarticular Triamcinolone acetonide, pro-inflammatory
cytokines concentrations were significantly increased in the synovial fluid following
ACL reconstruction. Furthermore, cytokine concentrations one week after surgery were
greater than what was observed approximately one week after the initial insult of injury.12
Our findings concur with previous findings of an increased inflammatory burden
following ACL reconstruction.86
The findings from this study establish the early time frame during which the
inflammatory process occurs. Joint inflammation after ACL reconstruction increases
immediately after surgery, and while pro-inflammatory cytokine concentrations begin to
reduce 4 weeks after surgery, they do not return to normal preoperative levels. Larsson et
al. found similar results, showing an increase in synovial fluid pro-inflammatory
cytokines up to 5 years post reconstruction, when compared to patients who had delayed
reconstruction.87 Consequently, this suggests that the elevations in IL-1b and IL-6 seen in
some of our patients may not return to normal for 5 years or longer. Interestingly, the
increase in chondral breakdown markers does not increase until 4 weeks or longer after
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the ACL reconstruction.12,88 This may suggest a time-related response of chondral
breakdown to the second “inflammatory hit”.
A state of increased and/or prolonged inflammation could contribute to
chondrodegenerative and bony changes observed in the first two years ACL
reconstruction thereby promoting the progression of PTOA. Chronic inflammatory
synovitis89,90 and several pro-inflammatory cytokines, most notably IL-1 and TNFa91,92,
have been closely linked to the progression of idiopathic OA. Furthermore, data from
animal studies emphasize the role of IL-1 and TNFa in the onset and progression of
OA,93 similarly pro-inflammatory stimulation of meniscus cells increases cytokine and
matrix metalloproteinase (MMP) activity.94
ACL reconstruction is a clinically successful procedure with patients reporting
improved outcomes 10 years following surgery.95 While ACL reconstruction successfully
restores joint stability, the biologic response to injury and subsequent surgery are not
sufficiently addressed by current approaches. Chronic posttraumatic inflammation and
seemingly related progressive chondral degradation should likely be addressed. Hence,
the treatment paradigm may need to be shifted to include treatments to address
inflammation outside of the immediate healing response window as described by
Anderson et al.96
There is evidence that biologic agents targeting the inflammatory process can
reduce inflammation and can potentially mitigate the early process of
chondrodegradation. For example, IL-1ra can reduce chondral lesion size and improve
outcomes in animal models and in an idiopathic OA population.97,98, 99 In a small
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randomized clinical trial IL-1ra has been shown to redcue pain and effusions after ACL
reconstruction.100 Our group has reported that intraarticular administration of 40 mg of
triamcinolone acetonide successfully alters the progressive increase in CTXII as marker
of cartilage degradation 4 weeks after ACL injury.12 In addition biologics such as platelet
rich plasma (PRP) and even more so, bone marrow aspirate concentrate (BMAC) have
been shown to contain an abundance of IL-ra and other anti-inflammatory cytokines and
could potentially be treatment options that need to be considered.101,102 Other potential
interventions that aim at reducing MMP and cytokine activity after acute knee injury may
alter the progression of PTOA,103 suggesting that perioperative anti-inflammatory
treatment may improve joint health following surgery.
Other modifiable factors to potentially mitigate the progression of PTOA could
include the timing of surgery and/or surgical technique. Traditionally, early
reconstruction was contraindicated due to the risk for the development of
arthrofibrosis.104 However, more recent literature suggests that earlier timing of ACL
reconstruction with early aggressive rehabilitation is not detrimental to the joint, and
outcomes following early surgery are consistent with those undergoing more traditional
surgical timing.21,105 Eriksson et. al21, suggested that early surgery may combine the
traumas of the initial injury and surgery. This would avoid a “second hit” to the joint21
potentially avoiding the re-initiation of the cartilage breakdown process. Along with the
timing of surgery, additional studies are necessary to determine if less invasive surgical
approaches like bridge-enhanced ACL repair106 or “biologic ACL repair” lessens the
magnitude of the “second hit” when compared to conventional ACL reconstruction.
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This pilot study is not without limitations. As this was a pilot study, the results
should be used for hypothesis generation and these preliminary results do not meet the
rigor necessary to modify the standard of care. However, the results of this study inform
us that fully-powered RCTs examining pre- and/or postoperative anti-inflammtory or
chondroprotective interventions are needed. As such, additional studies are necessary to
verify our findings and to develop evidence-based approaches to potentially offset the
postoperative inflammatory cascade and cartilage degradation. Second, the purpose of
these analyses was to assess inflammatory and cartilage biomarkers during the first
postoperative month, long term follow-up will be necessary to determine if the elevated
levels of proinflammatory and chondrodegenerative biomarkers persist after ACL
reconstruction and contribute to the progression of PTOA. This will be done in the future
as we are following this cohort of patients prospectively. Third, this well controlled pilot
study included relatively little variation in terms of the timing of surgery (average 23
days post injury). Additional studies are necessary to assess whether the timing of ACL
reconstruction – either acute or delayed – may dampen the postoperative inflammation
and cartilage degradation.

Conclusion
ACL injury leads to an initial inflammatory response that begins to subside over
the first several weeks after injury but is associated with chondral degradation. ACL
reconstruction within 3-4 weeks after ACL injury reinitiates both the inflammatory
response and subsequent cartilage degradation. Even with an anti-inflammatory treatment
administered post injury, this “second hit” to the joint was associated with both a larger
and more prolonged inflammatory response than the initial injury itself. This insight
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suggests that an early post-injury and/or postoperative intervention addressing prolonged
inflammation and associated chondral degradation may be needed in order to potentially
alter the progression of PTOA after ACL injury.
These results represent a critical step in understanding the complex interplay
between inflammation and cartilage breakdown following ACL reconstruction. We have
shown the progression of inflammatory biomarkers, both in response to the initial ACL
injury and after reconstruction. This provides insights into the timing of when antiinflammatory interventions could be most meaningfully applied. Further research is
necessary to explore treatment options that are both effective in reducing the
inflammatory response and cartilage breakdown to promote long-term joint health.
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Table 3.1 Meniscus pathology addressed at the time of ACL reconstruction
Medial

Lateral

No meniscus involvement

2 (14%)

2 (14%)

Meniscus Repair

6 (43%)

5 (29%)

Meniscectomy

1 (7%)

3 (21%)
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Figure 3.1 CONSORT enrollment flow chart.
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Figure 3.2 Inflammatory progression of IL-1b and IL-6 after ACL injury and
reconstruction.
IL-1b concentrations significantly increased one week post-surgery when compared to
initial presentation (p=0.015) and the day of surgery (p<0.001)(2). Four weeks postreconstruction IL-1b concentrations decreased but did not return back to day of surgery
levels (p=0.001)(1). There was a significant decrease in IL-6 from the time of initial
presentation to surgery (p<0.001)(a). IL-6 concentrations at 1 week post-surgery were
significantly greater than initial presentation (p=0.013), the day of surgery (p<0.001), and
4 weeks after surgery (p=0.002)(b). Four weeks post operatively, IL-6 concentrations
remained significantly higher than the day of surgery (p<0.001)(a)
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CHAPTER 4. UPREGULATION OF SYSTEMIC INFLAMMATORY PATHWAYS FOLLOWING
ANTERIOR CRUCIATE LIGAMENT INJURY RELATE TO BOTH CARTILAGE AND MUSCULAR
CHANGES: A PILOT STUDY
Abstract
In conjunction with cartilage breakdown, muscle maladaptation including atrophy
and increased fibrosis have been observed in the quadriceps following anterior cruciate
ligament (ACL) injury. Previously observed upregulated muscle-related proteins in the
synovial fluid following ACL rupture allude to cellular communication between the joint
and muscle. Therefore, the purpose of this study was to determine whether muscle-related
analytes are differentially expressed in the serum. Sixteen patients with an acute ACL
tear participated in this IRB-approved study. Serum was obtained at two different time
points at a mean 6 and 14 days post injury, and serum was analyzed by a highly
multiplexed assay of 1300 proteins. Pathway analysis using DAVID was performed;
genes included met three criteria: significant change between the 2 study time points
using a paired t-test, significant change between the 2 study time points using a Mann
Whitney non-parametric test, and significant Benjamini post hoc analysis. Twelve
analytes significantly increased between time points. Proteins chitinase-3-like protein 1
(p= .01), insulin-like growth factor binding protein 1 (p= .01), insulin-like growth factor
binding protein 5 (p= .02), renin (p=.004) and lymphotoxin alpha1: beta2 (p= .03) were
significantly upregulated in serum following acute ACL injury. The current results
confirm the inflammatory pattern previously seen in the synovial fluid thought to play a
role in the progression of post traumatic osteoarthritis after ACL injury, and this data also
provides further insights into important communication between the joint and quadriceps
group, whose function is important in long term health.
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Full Reference: Hunt, E. R., Villasanta‐Tezanos, A. G., Butterfield, T. A., Lattermann,
C., & Jacobs, C. A. (2020). Upregulation of Systemic Inflammatory Pathways Following
Anterior Cruciate Ligament Injury Relates to Both Cartilage and Muscular Changes: A
Pilot Study. Journal of Orthopaedic Research®, 38(2), 387-392.
Introduction
Traumatic anterior cruciate ligament (ACL) injury causes a deleterious cascade of
events including a robust inflammatory response and cartilage breakdown characterized
by increases in markers of cytokines and collagen catabolism that could lead to
chondrocyte death.8,12,74,75,107,108 Along with increased pro-inflammatory markers and
cartilage breakdown another hallmark of ACL injury is persistent long-term quadriceps
atrophy. Atrophy and weakness of this muscle group continues long after injury and even
surgical intervention, causing the joint to remain unstable due to a lack of strong dynamic
stabilization.1,3
Changes in quadriceps morphology post-injury suggest that acute ACL injury
affects not only the local environment within the synovial joint but the surrounding
structures as well. Following injury, the quadriceps muscle shows increased fibrosis,
decreased satellite cell number,30,31 and a decreased fiber cross sectional area indicating
atrophy. Furthermore, after ACL reconstruction, there are upregulations in common
muscle growth regulators including myostatin35 a widely studied signaling molecule of
the transforming growth factor-beta superfamily that induces atrophy by activating the
ubiquitin proteasome pathway (UPP).35 What remains unknown is the effect of the
inflammatory process on the quadriceps and its influence on changes in muscle. The
40

differential muscle morphology post injury is relevant because it lends evidence that the
joint and muscle may communicate cellularly. This cross-talk between systems could be
contributing to the persistent atrophy seen clinically and therefore may identify proteins
vital to the interplay between the inflamed joint and quadriceps muscle.
Previously, a study looking at the proteomic response in the synovial fluid to ACL
injury revealed upregulated muscle related analytes after injury.11 Muscle-related analytes
myoglobin and SMAD 2/3 are linked to muscle stress and cell growth, but were an
unexpected finding in the synovial fluid following acute ACL injury. Therefore, the
purpose of this study was to determine whether muscle-related analytes are differentially
expressed in the serum. We hypothesized that proteins related to muscle would be
increased in the serum after ACL injury, providing a means of transport to the synovial
fluid.

Methods
4.1.1

Study Design
This study represents a secondary analysis of samples collected as part of a

randomized clinical trial of patients with acute ACL rupture (clinicaltrials.gov:
NCT01692756). This RCT aimed to determine the effectiveness of early antiinflammatory treatment post ACL injury. 12 While the aim of this RCT was to determine
the effect of intra-articular triamcinolone acetonide, none of the patients included in this
subgroup analysis received a corticosteroid injection at either of the time points used in
the current analyses. Subjects included in this proteomic analysis were a part of the
placebo group who underwent blood collections via venipuncture, arthrocentesis and
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intra-articular saline injections (10 mL). Blood collection was performed on the day of
initial presentation (mean= 6 days post-injury, range = 2-8 days) and again between 6 and
12 days after initial presentation (mean=14 days post-injury, range = 8-20 days).
4.1.2

Patient Demographics
This study consisted of 16 patients (8 females, 8 males; mean age 18 years, range

15-26 years; mean body mass index 23, range 18-28 kg/m2) with acute ACL rupture.
Inclusion criteria were as follows: isolated ACL injury determined by clinical exam
(positive Lachman test with intra-articular effusion) that was corroborated using magnetic
resonance imaging (MRI); age 14 years or older; skeletally mature with closed growth
plates visualized by radiograph; no history of ipsilateral knee injury; ACL injury had to
occur during sports activities; no clinical evidence of posterior cruciate ligament
involvement; and no more than a grade 1 medial or lateral collateral ligament injury.
Exclusion criteria were: injury occurrence more than eight days before enrollment;
previous knee surgery; history of intra-articular cortisone injection into either knee within
three months of injury; or history of any inflammatory disorder.
ACL tear was confirmed intraoperatively at the time of reconstruction and preoperative MRI ensured there were no concomitant ligamentous injuries. Patients were
instructed to avoid any prescription or over the counter anti-inflammatory medications
but were allowed to use rest and ice to manually control swelling. All patients received
the same rehabilitation protocols which included home based exercises focused on range
of motion and quadriceps muscle activation.109
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4.1.3

Proteomic Analyses
Similar to analyses previously performed on synovial fluid samples,11 serum

samples were collected for proteomic analysis with a high throughput and highly
multiplexed assay (SOMAscan version 3, SomaLogic, Inc., Boulder, CO). The technique
uses aptamers, chemically modified oligonucleotides that recognize the 3-dimensional
structure of proteins with high specificity and high sensitivity. Each aptamer is tagged
with a DNA sequence enabling quantification using a hybridization array. The assay
converts the measurement of proteins into the measurement of corresponding DNA. Data
are recorded for each of the 1317 proteins as relative fluorescent units (RFU). The
coefficient of variation for the SOMAscan Assay is 5% (somalogic.com/somascan-assayfaqs).
4.1.4

Statistical Analysis
Paired t-tests were used to determine differences between biomarker levels at the

two preoperative time points for each analyte. Due to the small sample size, standardized
response means (SRMs) were also calculated to potentially identify any trends within the
data. SRM is the pre- to post change divided by the standard deviation of the change
scores for that particular variable, and values of >0.8 are considered large.110,111 In
general, higher values of these proteins would reflect a state of greater inflammatory
response and a potential propensity for osteoarthritic changes and progression. We also
included an exploratory group of five analytes previously found to be upregulated in the
synovial fluid that are related to skeletal muscle (myoglobin, SMAD 2/3, CDON, and
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fibronectin), three related to inflammation (IL-1b, TGFb and TNFa) and one related to
cartilage breakdown (MMP-1).11
The Database for Annotation, Visualization and Integrated Discovery (DAVID
Bioinformatics Resources, National Institute of Allergy and Infectious Diseases, NIH)
was used to complete the pathway analysis. To be included in the post-hoc pathway
analysis, genes had to pass three different statistical tests. All of the genes had to have a
significant change between the two study time points using a paired t-test, a significant
change between time points using a Mann-Whitney nonparametric test and significant
Benjamini post hoc analysis. Upregulated pathways were identified using The Gene
Functional Analysis Tool, with Benjamini post hoc analyses to account for multiple
comparisons.112,113 Non-parametric Spearman correlations were used to determine
potential relationships between analytes that were significantly upregulated and a known
marker of cartilage breakdown (MMP-1). Prior to running the correlations, a Grubbs test
for outliers was used to determine the presence of any outliers within the data set. Alpha
was set at 0.05 a priori.

Results
4.1.5

Analytes with Largest Increase
There were 1,317 analytes measured in total.11 Of those, 12 demonstrated the

largest changes in the serum within the first two weeks after injury (Table 3.1). Even with
a small sample size, moderate to large changes in analyte concentrations between time
points (SRM ranges -0.58 to 0.69) were observed. There were five analytes that
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significantly increased in concentration in the serum within the first two weeks after ACL
injury and seven that significantly decreased (p<0.05).
A Grubbs test revealed one outlier within the MMP-1 group (p<0.05), therefore
that subject was excluded from the correlation. There was a moderate correlation (rho
=0.64, p = 0.009) between the initial serum levels of Matrix Metallopeptidase 1 (MMP-1)
and the change in Insulin Like Growth Factor Binding Protein 5 (IGFBP-5; Figure 3.1).
4.1.6

Pathway Analysis
Four distinct pathways were identified using DAVID analysis. These include

complement and coagulation cascades (p=0.003, three analytes identified in this
pathway), NF-κβ signaling pathway (p=0.004, three analytes identified), platelet
activation (p=0.009, three analytes identified) and ghrelin (p=0.05, two analytes
identified). Analytes associated with each specific pathway can be found in Table 3.2.
4.1.7

Analytes Previously Linked to Skeletal Muscle and Inflammation
There were no significant changes in any of the muscle related analytes,

inflammatory, or cartilage breakdown markers (Table 3.3). Of these analytes, fibronectin,
myoglobin, MMP-1 and IL-1β were decreased whereas the others increased between the
two study time points, but not enough to be significant.

Discussion
The purpose of this study was to determine whether muscle-related analytes are
differentially expressed in the serum.11 This would provide a potential mechanism of
communication by which proteins may travel to the joint and influence the systemic
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environment. In a mouse model of knee OA, increases in inflammatory markers in the
serum preceded increases in IGFBP-5 in the muscle and subsequent muscle wasting.114
Similarly, acute ACL injury initiates a biochemical cascade with increased proinflammatory cytokines and increased markers of cartilage breakdown within the joint.12
Castillero also found increases in inflammatory markers in the serum that preceded
increases in IGFBP-5 in the muscle.114 The muscle related analytes previously found in
the synovial fluid11 were not significantly increased in the serum in the current study,
possibly because they are downstream in the signaling pathways. However, IGFBP-5 was
elevated in the serum which may have implications for the long-term changes seen within
the quadriceps muscle.
4.1.8

Intra-articular Inflammation and Upregulation of IGFBP-5
IGFBP-5 may have important implications for skeletal muscle atrophy after ACL

injury. Insulin growth factor (IGF) has important functions throughout the body but most
importantly, in this context, it is a potent skeletal muscle growth mediator115 and may
regulate cartilage matrix synthesis.116 Insulin like binding proteins (IGFBPs) regulate the
function of IGF and IGFBP-5 specifically mediates skeletal muscle differentiation and
possibly hypertrophy.115,117,118 IGFBP-5 is the predominatant growth factor binding
protein expressed in muscle119 and can regulate IGF by binding to it with an affinity as
high as binding with the IGF receptor. This then allows the binding proteins to influence
IGFs115, either by altering IGF actions117 or by switching on IGF-II.120 The regulation of
IGFBP-5 is more elusive but studies point to regulation by key micro RNAs121 like miR140.122
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The current study focused on the proteomic analysis after acute ACL injury but
there has been some research investigating the role of IGFBP-5 on skeletal muscle and
cartilage in induced OA models. Microarray analysis in rats with monoiodoacetate
induced OA showed upregulated gene clusters related to skeletal muscle development
and specifically increases in IGFBP-5 in animals with cartilage damage.123 Rats with
induced arthritis had significant upregulations in MuRF1, indicating muscle catabolism,
in conjunction with increased levels of IGFBP-5 in the gastrocnemius muscle.124 Induced
arthritis via adjuvant injection also showed significant increases in gastrocnemius
IGFBP-5 two weeks after injection as well as a significant decrease in gastrocnemius
muscle mass and serum IGF-1. Olney et al., found that chondrocytes from osteoarthritic
knees had increased expression of IGFBP-5116, theorizing it may play a role in cartilage
breakdown. Our data support this finding and demonstrated a strong correlation between
patient’s initial levels of MMP-1, a cartilage breakdown marker, and changes in IGFBP-5
(Figure 3.1). These positive correlations suggest a complex communication network that
is triggered by intraarticular inflammation and cartilage changes which then result in
increased systemic inflammatory markers and finally changes in skeletal muscle.
4.1.9

IGFBP-5 and Muscle Atrophy
In animal models, elevated IGFBP-5 and inhibition of IGF has been consistently

associated with atrophy. Stevenson et al. in 2003 found that in atrophied rat soleus
IGFBP-5 was elevated four-fold by day four of hindlimb unloading and remained
elevated at 14 days.125 In a study of mouse muscle overload and atrophy, researchers
found that the soleus muscle was atrophied by 20% after eight days of unloading, with a
two-fold increase in IGFBP-5 and a decrease in IGF-1 mRNA. After eight days of
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overload, IGFBP-5 mRNA remained significantly lower in overloaded skeletal muscle
than control muscles.126 Furthermore, overexpression of IGFBP-5 in a mouse model
resulted in reduced muscle fiber hypertrophy as well as an overall lower body mass
compared to control animals.118 Steves et al. demonstrated that the tibialis anterior
muscles did not grow as expected following reloading after atrophy in IGF overexpressing mice, and reported significantly elevated IGFBP-5 levels three weeks after
re-ambulation.127
Although quantifying muscle tissue specific IGFBP-5 levels was beyond the
scope of this study, our results suggest that IGFBP-5 may be systemically upregulated in
first two weeks after ACL injury. Circulating levels of IGFBP-5 presents a potential link
between traumatic joint injury and quadriceps atrophy. This finding uncovers an
interesting avenue for further investigation of the potential inhibition of IGF in the
quadriceps by IGFBP-5 leading to the quadriceps atrophy seen clinically. There are many
studies looking at the effects of IGFBP-5 in disuse atrophy and transgenic
knockout,118,120,126,127 but there is little evidence on its effects after traumatic joint injury.
A more in-depth exploration into the communication between IGF and IGFBP-5 post
ACL injury would be necessary to define its effects on both the joint and musculature. In
addition, future studies are necessary to determine if systemic changes in IGFBP-5 also
result in changes to not only the quadriceps but other muscle groups as well (hamstrings,
gastrocnemius, etc.).
4.1.10 Differences Between Serum and Synovial Fluid Proteomics
Proteomic changes in the serum did not mimic changes in synovial fluid reported
previously, revealing fewer and much different analytes and upregulated pathways. While
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this was not expected, the upregulated analytes in the serum related to either clotting or
inflammation with the exception of the insulin-like growth factor binding proteins.
Pathways including complement and coagulation and platelet activation are to be
expected due to hemarthrosis into the knee joint after injury.128 ACL injury creates an
influx of pro-inflammatory markers, protein mediators and blood into the joint, which
may perpetuate the cartilage damage.129 Since synovial fluid is an “ultrafiltrate” of
plasma and not a static protein pool,130 contents continuously filter in and out of the joint.
Under healthy conditions, there is flow of synovial fluid over the synovial interstitial
space that turns over allowing in and out flux of transudate. During periods of trauma the
transudate becomes exudate, a protein filled fluid that resides extracellularly in the
synovium.130
After ACL injury in particular, the length of time that hyaluronan is present in the
joint decreases suggesting that there is a transport system for altered synovial fluid post
injury.131 Moreover, the molecular sieve theory postulates that hyaluronan chain length
filters the synovial fluid only allowing molecules between 33-59 nm into the articular
space132, thus only allowing certain proteins to flow back and forth. Synovial fluid
filtration post injury may be a possible explanation as to why the analytes that were
upregulated after injury in the synovial fluid were not the same as those upregulated in
the serum. Persistent muscular dysfunction after ACL injury is undoubtedly a complex,
multifactorial injury but better understanding the communication between the intra- and
extraarticular environments is important in identifying the underlying mechanisms and
potential treatment targets.
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4.1.11 Limitations
This pilot study of the proteomic response to ACL injury in human serum is not
without limitations, particularly that an a priori power analysis was not used for sample
size. This study included 16 subjects following acute, isolated ACL injury, which limits
conclusions that can be drawn and if these results are generalizable to other populations.
The progression of inflammation following ACL injury is multifaceted and previous
studies show that variables like body mass index, sex and age all effect this
progression133, and should be included in further analysis. These data provide insight into
the systemic response after ACL injury and indicate that the effect in serum differs from
that in synovial fluid. The present study used samples from two early time points after
injury but demonstrates that proteomic analysis can be valuable in determining potential
communicating factors between the intra- and extraarticular environments after ACL
injury. Future studies focused on the influence of inflammatory and skeletal muscle
markers on cartilage is necessary to determine the interplay between the local joint
environment and surrounding structures.

Conclusions
ACL injury affects not only the knee joint but the surrounding musculature as
well. The current proteomic analyses identified analytes that could have implications for
inflammation, muscle atrophy, and cartilage health. The proteomic analysis of the serum
provided insight into systemically upregulated analytes that could be important for
communication between the inflamed joint and subsequent changes in muscle.
Identifying key players in the communication between the intra- and extraarticular
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environments will be crucial to developing successful interventions for the prevention of
muscle atrophy and cartilage breakdown. Further investigations will be necessary to
elucidate the relationship of analytes like IGFBP-5, inflammation, and muscular changes
after ACL injury.

Table 4.1 Twelve analytes that were significantly up or down regulated between the time
of ACL injury and one-week post injury.
All values are expressed in relative fluorescent units (RFU; mean ± standard deviation).
Protein

Time 1

Time 2

P

SRM

Chitinase-3-like protein 1

5468.9 ± 3369.2

8102.8 ± 6508.8

0.015

0.69

Insulin-like growth factor-binding

1697.6 ± 323.04

1992.9 ± 531.9

0.015

0.69

659.6 ± 389.9

1070.6 ± 816.6

0.030

0.60

Renin

368.0 ± 109.6

435.1 ± 96.3

0.032

0.59

Lymphotoxin alpha1: beta2

193.2 ± 52.8

238.3 ± 96.7

0.038

0.57

Cathepsin Z

3006.1 ± 751.1

2497.4 ± 778.8

0.034

-0.58

Fibrinogen

32497.3 ± 12149.5

25956.5 ± 7428.3

0.024

-0.63

Carbonic anhydrase 6

10018.4 ± 4794.5

8828.9 ± 4425.8

0.005

-0.63

Fibrinogen gamma chain

7449.6 ± 2530.2

5850.8 ± 1547.8

0.020

-0.65

Lipopolysaccharide-binding protein

45316.3 ± 10568.0

36271.2 ± 12465.6

0.015

-0.69

protein 5

Insulin-like growth factor- binding
protein 1
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Table 4.1(continued)

C-reactive protein

11677.4 ± 12578.4

5246.2 ± 6217.1

0.012

-0.71

Parathyroid hormone

1169.3 ± 317.3

961.7 ± 226.7

0.007

-0.79

Table 4.2 Analytes identified for each of the significant pathways
Pathway

Analytes

Complement and coagulation cascades

Fibrinogen alpha chain (FGA)
Fibrinogen beta chain (FGB)
Fibrinogen gamma chain (FGG)

NF-kappaβ

Lipopolysaccharide binding protein (LBP)
Lymphotoxin alpha (LTA)
Lymphotoxin beta (LTB)

Platelet activation

Fibrinogen alpha chain (FGA)
Fibrinogen beta chain (FGB)
Fibrinogen gamma chain (FGG)

Ghrelin

Insulin like growth factor binding protein 1 (IGFBP1)
Insulin like growth factor binding protein 5 (IGFBP5)
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Table 4.3 Muscle, inflammatory and cartilage related analytes between the time of injury
and one-week post injury.
All values are expressed in relative fluorescent units (RFU; mean ± standard deviation).
Muscle Related Analytes

Time 1

Time 2

P

SRM

Cell adhesion molecule-

5028.8 ± 1293.7

5240.1 ± 1323.0

0.42

0.21

Fibronectin

11152.4 ±
4289.1

8621.0 ± 5605.3

0.15

-.38

Myoglobin

1046.1 ± 368.8

889.1 ± 405.5

0.31

-0.26

Mothers against decapentaplegic

983.3 ± 479.6

8628.3 ±
27301.5

0.28

0.28

2997.6 ± 1625.0

3258.0 ± 3316.6

0.76

0.08

related/down-regulated by
oncogenes

homolog 2

Mothers against decapentaplegic
homolog 3
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Table 4.3 (continued)
Inflammatory Related Analytes

Time 1

Time 2

P

SRM

Interlukin 1 Beta

1129.1 ± 571.

918.9 ± 491.7

.20

-0.33

Transforming growth factor beta-

1509.0 ± 929.3

1810.7 ± 1707.0

0.46

0.19

Tumor necrosis factor alpha

388.9 ± 208.3

470.4 ± 422.4

0.38

0.23

Cartilage Related Analytes

Time 1

Time 2

P

SRM

Interstitial collagenase

937.2 ± 586.9

113.4 ± 977.2

0.67

-0.11

1

Figure 4.1 Scatter plot depicting a significant (p=.009) positive linear relationship
between time A matrix metallopeptidase 1 (MMP-1) and the change in insulin like
growth factor binding protein 5 (IGFBP5).
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CHAPTER 5.

PHYSIOLOGICAL CHANGES TO THE VASTUS LATERALIS AFTER NON-INVASIVE
ANTERIOR CRUCIATE LIGAMENT INJURY

Abstract
Insufficient recovery of quadriceps muscle strength is commonly reported after
anterior cruciate ligament (ACL) injury. Although weakness is secondary to a complex
manifestation of neural inhibition, the extent and time course of morphological changes
in muscle are largely unknown. Using a novel, clinically relevant animal model of ACL
injury, a longitudinal study was performed to illuminate mechanisms underlying muscle
atrophy. Purpose To investigate changes in cellular parameters underlying muscle
function after non-invasive ACL rupture. Methods Male Long-Evans rats were randomly
assigned to 8 groups (n=6-8 per group): one control group and seven groups after ACL
injury (time after injury: 6, 12, 24, 48-hours, and 1, 2, 4-weeks). The right hindlimb of
rats in the ACL-injury group were exposed to a single load of tibial compression to
induce a non-invasive ACL rupture, followed by normal cage activity for designated
time. The vastus lateralis (VL) muscles were immunoreacted for IgG, Pax7 and
dystrophin to quantify muscle damage, satellite cell number and muscle fiber cross
sectional area (CSA) respectively. The mRNA abundance of muscle RING-finger
protein-1 (MuRF-1), muscle atrophy F-box (MAFbx) (markers of protein degradation),
45s pre-rRNA (marker of ribosome biogenesis) and CD68 (marker for macrophage
abundance) was determined by RT-PCR. One-way ANOVAs with Bonferroni post-hoc
were used to determine differences between groups and paired t-tests were used to detect
differences between limbs (P < 0.05). Results ACL injury resulted in a decrease in
muscle wet weight (p=0.0003) and a trend toward reduced CSA (p=0.06) at 1-week post
injury only, compared to control. CSA of the ACL injured limb was smaller than that of

the contralateral limb at 1-week only (p= 0.01). MAFbx mRNA abundance was
significantly increased at 48-hours post-ACL injury (p=0.0001), with no differences for
IgG, central nuclei, Pax7, 45s rRNA, total RNA concentration, CD68 or MuRF-1.
Conclusions Results indicate that ACL injury induces atrophy which is transient and not
related to muscle damage or changes in ribosome biogenesis but could be due to
increased protein degradation. Based on these analyses future studies should focus on
corroborating the increase in atrophic pathways and determining the presence of protein
breakdown after ACL injury, to establish key therapeutic windows for targeting therapyresistant quadriceps weakness after ACL injury. Supported by K01AR071503.
Keywords: Anterior cruciate ligament, quadriceps, atrophy

Introduction
Anterior cruciate ligament (ACL) injuries are one of the most common
musculoskeletal injuries with an incidence rate of upwards of 200,000 cases a year.1 One
detrimental result of ACL injury is persistent long term quadriceps atrophy and
weakness.134-138 While the current standard treatment for ACL injury is surgical
reconstruction, surgery does not entirely solve the problem of muscle atrophy.139
Reconstruction surgery will reestablish joint congruity but patients who undergo surgery
and those who remain ACL deficient will have quadriceps atrophy and weakness. 23,24,140
ACL reconstruction and non-surgical treatment yield similar long term outcomes but
when compared to the contralateral leg or healthy controls, patients who have town their
ACL still have quadriceps atrophy and weakness.26 Furthermore, the incidence of
developing post traumatic osteoarthritis (PTOA) is similar for patients who undergo
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reconstruction as for those who remain ACL deficient (ACLD), indicating a need for
interventions that will help preserve long term joint health. Patients with decreased
quadriceps muscle strength have a higher incidence of PTOA likely due to the
quadriceps’ inability to mitigate force through the joint. Therefore, elucidating the
sources of quadriceps weakness following ACL injury is imperative in developing proper
interventions.
Quadriceps atrophy following ACL injury is multifactorial including alterations in
neural inhibition17-19 and muscle morphology30,31,33. In comparison to what is known
about alterations in neural inhibition, less is known about the cellular responses of the
quadriceps muscle itself. Following ACL injury there are decreases in both physiological
cross sectional area and fiber cross sectional area, with the largest decreases in the vastus
lateralis between injured and non-injured limbs.29,30 There are also abundant increases in
collagen content and fibrosis following injury31,33 that is associated with decline in
satellite cell abundance.30,31 This could have important implications for function because
increases in fibrosis and a decreased muscle stem cell abundance could limit muscle
hypertrophy and muscle regrowth31. Additionally, there is a rise in myostatin expression
in both the muscle and circulating serum levels33,35.Myostatin is an important muscle
growth mediator34 and could be involved in atrophy following injury. Furthermore,
studies looking at human muscle biopsies following ACL injury show higher levels of
inflammatory mediators like TNFa and IL-633, presenting an inflammatory response in
the muscle following joint injury. These studies provide an important first step in
understanding the response of the quadriceps muscle following injury. Studies involving
human subjects are mostly cross sectional and due to the variability and constraints of
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human research, these studies are confounded by long periods between injury and biopsy
as well as reconstruction surgery. Therefore, there is a need for longitudinal studies that
will provide insight into timing and mechanisms underlying vastus lateralis atrophy after
ACL injury.
Pre-clinical animal models of ACL transection provide a more controlled way to
study the effects of ACL injury. The use of animal models allows researchers to study
time points, like acutely after injury, that would not be feasible in human studies.
However, transection surgery introduces more confounding variables similar to
reconstruction surgery like an increase in inflammation and upregulation in certain
atrophic markers.36,37,41 A non-invasive model of ACL injury would allow for a
translational approach to determining the mechanisms responsible for muscle atrophy.
Therefore, the purpose of this study was to use our in vivo pre-clinical model of ACL
injury to systematically study the quadriceps muscle at several time points after injury.
We hypothesized that following ACL injury, atrophy would set in early after injury,
preceded by damage and inflammation in the muscle, and would continue for the duration
of the study, up to four weeks after injury.

Methods
5.1.1

Animals
All procedures performed were approved by the University of Connecticut’s

Institutional Animal Care and Use Committee. Male Long Evans rats, aged 16 weeks,
were used for this study. Animals were housed at the University of Connecticut division
of animal research facility. Rats were kept in normal sized cages on a 12:12 light/dark
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cycle and had access to food and water ad libitum. Rats were randomly divided into
seven experimental groups (6 hr (n=6), 12 hr (n=6), 24 hr (n=6), 48 hr (n=6), 1 wk (n=8),
2 wk (n=8), 4 wk(n=8)) and one sham uninjured group (n=6). The right hindlimb was
subject to ACL tear and after recovery animals were euthanized corresponding to the
group time point.
5.1.2

ACL Tear
Upon arriving at the vivarium, rats underwent a one week acclimatization period.

Rats that were randomly assigned to the ACL injury group, underwent a reproducible
non- invasive ACL injury using a single load of tibial compression. The custom device
consists of two custom-built loading platforms. The top knee stage is rigidly mounted to a
linear actuator (DC linear actuator L16-63-12-P, Phidgets, Alberta, CA) that positions the
right hindlimb in 30 deg of dorsiflexion and 100 deg of knee flexion while providing
room for anterior subluxation of the tibia relative to the femur. The bottom stage holds
the flexed knee and is mounted directly above a load cell (HDM Inc., PW6D, Southfield,
MI). Rats are anesthetized using an induction chamber with 5% isoflurane and 1L/min
oxygen and maintained via a nose cone with 2% isoflurane and 500mL. The right
hindlimb is subjected to single load of tibial compression at a speed of 8mm/s. ACL
injury is noted by a release of compressive force during injury that was monitored via a
custom program (LabVIEW, National Instruments, Austin, TX). Post-injury, study
personnel perform a Lachman’s test to clinically confirm an ACL rupture has occurred
and the hindlimb was palpated to check for the presence of gross bone deformity. If no
contraindications were present, rats were returned to their cages and allowed to recover,
no opioids or analgesics were administered due the ability for these drugs to alter normal
60

biologic responses. Following euthanasia rats were weighed and bilateral vastus lateralis
muscles were harvested, weighed, flash frozen and stored at -80 degrees for further
analysis. The right hindlimb was used for all analyses, except for CSA where both
hindlimbs were utilized.
5.1.3

Immunohistochemistry

IgG. To determine whether muscle fibers from the vastus lateralis exhibited overt
muscle damage, fibers were immunoreacted for immunoglobulin G (IgG)
infiltration141,142. Sections (8µm) were fixed in ice cold acetone (100%) for 10 minutes
and washed in phosphate buffered saline (PBS). Slides were then incubated in fluorescein
isothiocyanate-conjugated mouse anti-IgG (Invitrogen, Carlsbad, CA) overnight at 4°C.
Following incubation, slides were washed twice in 5% bovine serum albumin and then
once in PBS. To finish, sections were coverslipped using Vectashield mounting medium
(H-1000, Vector Laboratories, Burlingame, CA). Images were captured using a Zeiss
Axio Imager M1 microscope (Carl Zeiss, Göttingen, Germany). Five fields, taken to
reflect the non-homogenous nature of the muscle, to ensure that all areas of the muscle
were represented were photographed (100x) and subsequently analyzed using ZEN blue
software (Carl Zeiss). Fluorescent intensity was quantified by the densitometric mean of
each fiber (AU, arbitrary units) as previously described.142 IgG density, a marker of overt
fiber damage was counted by a trained-blinded assessor. Pax7. To quantify the
abundance of Pax7+ cells (satellite cells)142,143, slides were fixed in 4% paraformaldehyde
and underwent antigen retrieval at 92°C using sodium citrate buffer. Endogenous
peroxidase activity was blocked using 3% hydrogen peroxide and then sections were
incubated in Pax7 primary antibody (Developmental Studies Hybridoma Study Bank,
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Iowa City, IA, USA) at a 1:100 dilution. Next muscle sections were immunoreacted with
biotin conjugated secondary antibody (1:1000) (Jackson ImmunoReseach Laboratories,
West Grove, PA, USA) and then streptavidin-horseradish peroxidase to amplify. Sections
were then reacted with using TSA-Alexa fluor 488 (Invitrogen, Carlsbad, CA) and
stained with DAPI to visualize nuclei. Pax7+/DAPI+ nuclei were expressed per number
of muscle fibers. Dystrophin/Central Nuclei. Mean fiber cross sectional area (CSA) was
determined by immunoreacting muscle sections with dystrophin (Thermo Fischer
Scientific, Waltham, MA) primary antibody for 1 hour at room temperature and then
overnight at 4°C. Sections were incubated with directly conjugated goat-anti mouse 488
secondary antibody. Sections were also immunoreacted with DAPI and then cover
slipped with Vectashield mounting medium. Images were captured using Zeiss
Axiovision software and Myovision analysis software144 was used to cculate mean fiber
cross sectional area of each of the muscle fibers. Central nuclei were determined by
counting all DAPI+ positive nuclei with clear separation from the dystrophin border by a
blinded trained assessor145.
5.1.4

RNA Isolation and Real Time RT-PCR

RNA isolation was performed briefly as follows143,146. VL tissue was homogenized using
a stick homogenizer in 1 mL of Trizol (Invitrogen, Carlsbad, CA). Homogenized muscle
was spun at 12,000 g for 15 minutes and the supernatant was collected and added to 200
µl chloroform. Tubes spun again at 12,000 for 15 minutes and the aqueous layer was
taken for precipitation. Once precipitation occurred, the pellet was washed and
reconstituted using RNAse free water. RNA concentration was measured using a Nano
Drop (Thermo Fisher Scientific, Foster City, CA). Quantitative real-time reverse
62

transcription polymerase chain reaction (RT-PCR) was preformed using chemistry,
protocol and the amplification and detection of Applied Biosystems (Thermo Fisher
Scientific, Foster City, CA). For each sample cDNA was synthesized from 1 µg of total
RNA using iScript Reverse Transcriptase according to manufacturer’s protocol (Biorad,
Hercules, CA). Primers were selected using the Primer Design function of the Primer
Express v1.5 software (Applied Biosystems, Foster City, CA) and were as follows: 18s
(M11188) forward, TTCGGACGTCTGCCCTATCAA, reverse,
ATGGTAGGCACGGCGACTA; tubulin (NM 022298) forward,
GGCATGGAGGAGGGAGAGTT, reverse, CCAACCTCCTCATAATCCTTCTCTAG;
β2-microglobulin (NM 012512.2) forward CGTGCTTG CCATTCAGAAAA, reverse
GAAGTTGGGCTTCCCA TTCTC; muscle atrophy F-box (MAFbx) (NM 133521)
forward, GACCTGCATGTGCTCAGTGAA, reverse,
GGATCTGCCGCTCTGAGAAGT; muscle RING finger protein-1 (MURF1) forward,
TGCCCTGCCAGCACAAC, reverse, GGATTGGCAGCCTGGAAGAT; 45s forward,
GAACGGTGGTGTGTCGTT, reverse, GCGTCTCGTCTCGTCTCACT; CD 68,
forward, TGTCTGATCTTGCTAGGACCG, reverse,
GAGAGTAACGGCCTTTTTGTGA. PCR reactions for 18s, b2-microglobulin, tubulin,
MuRF1, MaFbx, 45s and CD68 were assemble using the SYBER Green PCT Master
Mix, which only required the addition of cDNA template and the primers mentioned
above. Data points for the standard curve were generated using threefold serial dilutions
of pooled cDNA. The reactions were performed using ABI PrimsTM 7700 Sequence
Detection System (Applied Biosystems) and the systems universal cycling conditions.
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RNA abundance was expressed a ratio that was normalized to the Geomean (Tubulin, 18s
and b2-microglobulin).143,146
5.1.5

Statistical Analysis
Using PRISM 8 software, one-way ANOVA with a Dunnett’s test was used to

determine significance between ACL-injured groups and control. For within group
comparisons, paired t-tests were utilized. All values reported are mean ± standard error of
the mean (SEM) and statistical significance was assumed at P<0.05.

Results
There were significant differences in VL wet weight with the one-week time point
being lower compared to control (p=0.001) and muscle weight to body weight ratios at
the one-week (p=0.001) and two-week (p=0.025) time points being lower compared to
the control group (Figure 5.1). Muscle fiber CSA was lower and trending towards
significance at the one-week time point (p=0.06) compared to control. To confirm that
this muscle atrophy seen at one week was due to the injury and not the animals losing
weight we compared fiber CSA of the left (non-injured) and right (injured limbs). The
right limb at the one-week time point was significantly decreased compared to left
(p=0.011) (Figure 5.2).
There were no differences in IgG infiltration between any of the experimental
groups compared to control (p=0.310), indicating that the VL muscle did not undergo
overt muscle damage in response to the ACL injury (Figure 5.3). There were also no
differences in the number of central nuclei per fiber (p=0.690) (Figure 5.4). CD68,
macrophage marker, mRNA abundance was not different between any of the
64

experimental groups and control (p=0.0363). mRNA abundance of TNFa, IL6 and IL10
was not detectable in our tissues (Figure 5.5). There were no differences in Pax7+
satellite cells abundance between the groups (p=0.210) (Figure 5.6).
Next we looked at specific atrophic markers, MuRF1 and Mafbx and found that
Mafbx at the 48 hour time point (p=0.004) was significantly higher compared to control
(Figure 5.7), but MurF1 was not different (p=0.296) at any time point. There were no
significant differences in RNA concentration (p=0.221) or 45s pre-ribosomal RNA
(p=0.368) (Figure 5.8).

Discussion
Results from this study show that following ACL injury atrophy of the quadriceps muscle
begins as early as 1 week post injury. In our model we found fiber atrophy at one-week
that was preceded by increases in an atrophic marker at 48 hours post injury. These data
parallel previous longitudinal studies36,41 which showed increases in MaFbx and Murf1
three days post ACL transection surgery. This is important because it provide insights
into the period when atrophy is beginning which may have implications in developing
interventions to treat muscle atrophy following ACL rupture. The model we utilized here
is fundamentally different from other pre-clinical models considering the mode in which
injury was induced. Surgical ACL transection models confound the data because
opening the joint during a transection procedure causes an increases in inflammation and
upregulations in atrophic markers, in both the ACL transection group and the sham
surgery group.36,41 Increases in protein degradation markers would imply that the atrophy
seen in the quadriceps is a function of the surgery and not the injury.36 Our model is a
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closed ACL injury, meaning we induce ACL injury without opening the knee joint.
Therefore, the decreases we see in muscle size and increases in atrophic markers
demonstrates that these processes are in fact caused by injury to the ligament and will
happen regardless of surgery.
In conjunction with looking at markers of atrophy we also looked at RNA
concentration, an indicator of ribosome quantity or translational capacity, and preribosomal RNA, an indicator of RNA transcription. Increases in pre-ribosomal RNA may
indicate an increased capacity for ribosome biogenesis. While this is not a direct measure
of protein synthesis, these markers could begin to discern changes in a cell’s capacity for
protein synthesis.147 While our data did not find any differences in RNA concentration or
45s pre-rRNA, we did see a rebound in muscle size. CSA was increased back to control
level by two weeks, which could be due to the animals using their hindlimb more
normally as they recover from injury but remains different from how humans respond to
this injury, who do not recover muscle size. Animals in this study were allowed to use
their limb unrestricted after ACL injury which is a departure from how human patients
are treated; they are traditionally put in a brace following ligament injury. Bracing does
not aid in restoring normal biomechanics or function to the joint148 and immobilization of
the knee may aid in quadriceps atrophy.149 There is evidence to support that rehabilitation
preceding ACL reconstruction is helpful in restoring patient function after surgery150,151
but elucidating the timing of when atrophy begins, will help clinicians determine the most
appropriate treatment immediately following injury. Furthermore, few studies have
investigated changes in protein synthesis following ACL injury, but the interplay between
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protein synthesis and degradation is important and futures studies need to determine how
protein synthesis is changing in response to injury and an increase in atrophy.
This was one of the first study to investigate markers of muscle damage in the
vastus lateralis following ACL injury. Along with IgG infiltration, to confirm the absence
of overt injury, we counted central nuclei, and satellite cells which are necessary for
muscle regeneration152, and also saw no differences in these markers in any of the
experimental groups. The lack of damage insides fibers in our tissues demonstrates that
our model was successful in administering a joint injury without disruption to the
surrounding musculature and bone. This indicates that the atrophy we see at one week is
due to the effects of ligament rupture and not a response to damaging stimulus.
Moreover, we also found no differences in CD68 RNA indicating there were no
differences in macrophage abundance between groups in the muscle. The lack of
inflammatory markers in our muscle samples is a departure from what is seen in the
human studies where inflammation has been detected in the vastus lateralis muscle33 and
serum.35 Differences in the inflammatory response following ACL injury could be due to
the length of time between injury and biopsy or the absence of surgical intervention in
our model. Human studies looking at the effects of ACL injury on quadriceps muscle are
limited by the timeframe in which they can collect samples from their patients and on
average the time between injury and muscle collection is almost three months.30,31,33 It is
likely that we did not find the same response in the muscle as previous human literature
because our model was looking at acute post-injury time points and the response of the
muscle may be different early after injury. In the time between injury and sample
collection there is the possibility that patients could have been exercising or involved in
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rehabilitation that may increase inflammatory markers in the muscle and serum.153,154
This could explain the differences between the inflammatory response seen in the muscle
of human subjects in previous studies and our model presented here.
This study is not without limitations as this was the first step in beginning to
understand how the quadriceps responds to closed ACL injury in the early acute phase
after injury. Our latest time point was four weeks post injury and based on human
literature it is likely that there may be alterations to the quadriceps as far out as three
years after injury. We also did not include a sham treatment group in our studies to see
how positioning the animal’s hindlimb into the apparatus only without the injury, would
affect the muscle. Lastly, we did not look at any markers of fibrosis or protein breakdown
and in the future, these would be important additions.

Conclusions
This study was an important first step in understanding how ACL injury affects the
quadriceps in the acute injury phase. This study utilized a novel device to induce a closed
ACL tear and longitudinally studied the quadriceps muscle physiology over time. There
was no overt damage or inflammation to the muscle but there were upregulations in
atrophic markers at 48 hours and fiber atrophy at 1 week that may be important in
developing and implementing interventions to combat the muscle atrophy seen clinically.
Future studies should focus on continuing to elucidate the mechanisms behind quadriceps
atrophy in response to ACL injury.
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Figure 5.1 Muscle weight is lower at 1 week post ACL injury indicating atrophy in the
vastus lateralis.
Differences in muscle wet weight between time points, “$” indicated that one week is
different from control (p=0.001). Significant decreases in muscle weight to body weight
ratio for the 1 week (p=0.001) and 2 week (p=0.025) time points compared to control
(con (n=6), 6 hr (n=6), 12 hr (n=6), 2 hr (n=6), 48 hr (n=6), 1 wk (n=8), 2 wk (n=8), 4 wk
(n=8)). All values reported are mean ± standard error of the mean (SEM).
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Figure 5.2 Vastus Lateralis atrophy at 1 week following ACL injury.

Representative pictures of vastus lateralis cross-sectional area stained with dystrophin
(green) for control and 1 week groups. Decreases in fiber CSA at the 1 week time point
trending towards significance (p=0.06). Significant decreases in fiber CSA in the right
limb compared to the left limb for the one 1 week animals (p=0.011. Con (n=6), 6 hr
(n=6), 12 hr (n=6), 2 hr (n=6), 48 hr (n=6), 1 wk (n=8), 2 wk (n=8), 4 wk (n=8). All
values reported are mean ± standard error of the mean (SEM).
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Figure 5.3 ACL injury does not cause overt muscle damage.

Representative pictures of IgG photos from a control and 6-hour animal. No differences
in IgG density between any of the time points (con (n=4), 6 hr (n=6), 12 hr (n=6), 2 hr
(n=6), 48 hr (n=6), 1 wk (n=8), 2 wk (n=8), 4 wk (n=8)) and control (p=0.310). All
values reported are mean ± standard error of the mean (SEM).
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Figure 5.4 ACL injury does not increase the number of central nuclei.
Representative images of central nuclei from a control and 48 hour animal. No
differences in the number of central nuclei per fiber between any time point (con (n=4), 6
hr (n=6), 12 hr (n=6), 2 hr (n=6), 48 hr (n=6), 1 wk (n=7), 2 wk (n=8), 4 wk (n=8)) and
control (p=0.690). All values reported are mean ± standard error of the mean (SEM).
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Figure 5.5 No differences in CD68 mRNA abundance after ACL injury.
There were no differences in CD 68 gene expression in the injured limb between any of
the time point (con (n=6), 6 hr (n=4), 12 hr (n=6), 2 hr (n=6), 48 hr (n=5), 1 wk (n=7), 2
wk (n=8), 4 wk (n=6)) compared to control (p=0.363). All values reported are mean ±
standard error of the mean (SEM).
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Figure 5.6 No differences in Pax7+ cells after ACL injury.
Representative photos of Pax7+ cells (green) from control and 12-hour groups. There
were no differences between Pax7+ cells per fiber between any of the time point (con
(n=6), 6 hr (n=6), 12 hr (n=6), 2 hr (n=6), 48 hr (n=6), 1 wk (n=8)) compared to control
(p=0.210). All values reported are mean ± standard error of the mean (SEM).
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Figure 5.7 No differences in RNA concentration or pre-ribosomal RNA after ACL injury.
RNA concentration is not different between control (con (n=7), 6 hr (n=6), 12 hr (n=6),
24 hr (n=6), 48 hr (n=6), 1 wk (n=8), 2 wk (n=8), 4 wk (n=8)) and any other time point
(p=0.221). There is no difference in 45s gene expression between control and every other
time point (p=0.368). All values reported are mean ± standard error of the mean (SEM).
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Figure 5.8 Difference in Murf-1 and Mafbx gene expression after ACL injury.
Murf-1 gene expression is not different between control (con (n=7), 6 hr (n=6), 12 hr
(n=6), 2 hr (n=6), 48 hr (n=6), 1 wk (n=8), 2 wk (n=8), 4 wk (n=8)) and any other time
points (p=0.296). Mafbx gene expression is significantly higher at 48 hours when
compared to control (p=0.004). All values reported are mean ± standard error of the mean
(SEM).
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CHAPTER 6. SUMMARY
Purposes, Aims, and Hypotheses
The purpose of this dissertation is twofold: Firstly, to examine the relationship between
serum, synovial joint inflammatory markers and proteomics in ACL deficient subjects;
and 2. use those acquired data to identify cellular processes to track longitudinally in
conjunction with changes in muscle size following a closed ACL injury in a rat model.
These studies were designed to address the following aims and hypotheses:
1. To determine if patients who remain ACLD have atrophy and weakness of the of
the quadriceps compared to patients who undergo reconstruction.
Hypothesis: Patients who remain ACLD will have similar
functional outcomes as those who underwent surgery for isokinetic
muscle strength, the single leg hop test and the IKDC.
2. To assess inflammatory biomarkers before and after ACL reconstruction to
determine if surgery results in a secondary inflammatory response.
Hypothesis: We hypothesized that markers of inflammation
(interleukin-1b, (IL-1b), interleukin-6 (IL-6)) are significantly
increased following ACL reconstruction surgery.
3. To determine whether muscle-related analytes are differentially expressed in the
serum.
Hypothesis: We hypothesized that proteins related to muscle would
be increased in the serum after ACL injury, providing a means of
transport to the synovial fluid.
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4.

To use our in vivo pre-clinical model of ACL injury to systematically study the
quadriceps muscle at acute time points after injury
Hypothesis: following ACL injury there would be cellular changes,
such as damage, inflammation and atrophy, to the vastus lateralis
muscle.

Summary of Findings
The summary of findings for each specific aim are presented below. The findings include
the following:
1. To determine if patients who remain anterior cruciate ligament deficient (ACLD)
have atrophy and weakness of the of the quadriceps compared to patients who
undergo reconstruction.
Findings: The findings of this CAT imply that non-operative treatments of
ACL injuries are adequate options in restoration of patient function, as
well as patient strength at long term follow ups. However, patients who
remain ACL deficient still have atrophy and weakness of the quadriceps
for years following injury.
2. To assess inflammatory biomarkers before and after ACL reconstruction to
determine if surgery results in a secondary inflammatory response.
Findings: IL-1b concentrations significantly increased from the day of
surgery to the first postoperative time point (p<.001) and significantly
decreased at the 4-week postoperative visit (p=.03). IL-1b concentrations
at the 4-week postoperative visit remained significantly greater than both
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preoperative time points (p >.05). IL-6 concentrations at 1 week postsurgery were significantly higher than at initial presentation (p=0.013), the
day of surgery (p<0.001), and 4 weeks after surgery (p=0.002). ACL
reconstruction appears to reinitiate an inflammatory response and appears
to initiate a second “inflammatory hit”.
3. To determine whether muscle-related analytes are differentially expressed in the
serum.
Findings: Proteins chitinase-3-like protein 1 (p= .01), insulin-like growth
factor binding protein 1 (p= .01), insulin-like growth factor binding
protein 5 (p= .02), renin (p=.004) and lymphotoxin alpha1: beta2 (p= .03)
were significantly upregulated in serum following acute ACL injury. The
current results confirm the inflammatory pattern previously seen in the
synovial fluid thought to play a role in the progression of post traumatic
osteoarthritis after ACL injury, and this data also provides further insights
into important communication between the joint and quadriceps group,
whose function is important in long term health.
4. To use our in vivo pre-clinical model of ACL injury to systematically study the
quadriceps muscle at acute time points after injury
Findings: ACL injury resulted in a decrease in muscle wet weight
(p=0.0003) and a trend toward reduced CSA (p=0.06) at 1-week post
injury, compared to control. CSA of the ACL injured limb was smaller
than that of the contralateral limb at 1-week only (p= 0.01). MAFbx
abundance was significantly increased at 48-hours post-ACL injury
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(p=0.0001), with no differences for IgG, central nuclei, Pax7, 45s rRNA,
total RNA concentration, CD68 or MuRF-1.

Synthesis of Results and Future Research Implications
Several conclusions and implications for future research can be made based on the results
of these studies.
1. Patients who remain ACL deficient will have similar long term outcomes to those
patients that undergo reconstruction surgery. Although compared to healthy
controls and the contralateral side, patients who are ACL deficient will have
atrophy and weakness of the quadriceps for years after injury.
2. ACL reconstruction surgery reinitiates the inflammatory response within the knee
joint. Furthermore, surgery creates an inflammatory burden that is two-fold higher
than the initial ACL injury. The increased inflammatory burden has the potential
to influence the systemic and muscular environments, chronic increases in
inflammation may contribute to the detrimental side effects of ACL injury like
quadriceps atrophy, weakness and the development of OA.
3. Proteomic analysis revealed differences in upregulated proteins between ACL
injury and ACL reconstruction related to inflammatory pathways. Additionally,
upregulations in muscle related proteins provide a potential connection between
the systemic and muscular environments.
4. Pre-clinical models of ACL injury allow for a longitudinal, in depth study of
muscle physiology following ACL rupture. We showed that following closed
ACL injury there were no indications of inflammation or damage, there was
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however, atrophy at one week post injury. Fiber CSA atrophy was preceded by
increases in an atrophic marker, this may explain the decrease in muscle size and
gives insight into when atrophic processes begin following injury.

Conclusions
This dissertation sought to connect the synovial, serum and muscular
environments following ACL injury. We worked to determine how synovial joint
inflammation would affect the systemic and muscular environments using both human
and animal models. Our data began by elucidating that patients who do not undergo ACL
reconstruction surgery and remain ACL deficient will still have atrophy and weakness
long term when compared to healthy controls. This indicates that quadriceps atrophy
following injury is a result of the ligament rupture and will happen regardless of
reconstruction.
Moreover, we found a large increase in synovial fluid inflammatory markers
following surgery, almost two fold higher than the injury itself. These data highlight the
impact of inflammation on the synovial environment and may have implications for the
quadriceps muscle. In response to the large increase in synovial joint inflammation, we
found increases in serum circulating inflammatory proteins indicating an increase in
inflammatory pathways in the systemic environment. Additionally, there were
upregulations in proteins that may be associated in regulating muscle size providing a
connection between serum and the quadriceps muscle.
To further characterize the response of the quadriceps we used a novel pre-clinical
animal model of closed ACL tear. We looked at time points ranging from hourly after
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ACL injury up to four weeks out following injury and found that without the presence of
inflammation or damage in the muscle, the quadriceps muscle was still atrophied at one
week following injury. This atrophy was preceded by increases in atrophy markers forty
eight hours post injury and provides insight into when interventions may be appropriate.
These data provide important first steps in characterizing the response of the synovial
joint, serum and quadriceps muscle to ACL injury. Longitudinal studies like the one
presented here provide valuable insight into when interventions should be applied and
potential inflammatory targets. Future studies should focus on continuing to determine
the specific communication factors between these environments and developing
interventions to combat muscle atrophy following ACL injury.

Copyright © Emily Rose Hunt 2020
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